강영선

  #고혈압#당뇨#부종#투석#신질환#신장이식

학력

1990 ~ 1995 : 고려대학교 의과대학 학사
1997 ~ 1999 : 고려대학교 의과대학 석사
1999 ~ 2003 : 고려대학교 의과대학 박사

경력

1996 .03 ~ 1997 .02 : 고려대학교 의과대학병원 수련의
1997 .03 ~ 2002 .02 : 고려대학교 의과대학병원 전공의
2002 .03 ~ 2005 .02 : 고려대학교 의과대학 안산병원 전임의
2005 .03 ~ 2007 .02 : 미국 피츠버그 의과대학 박사후연구원
2007 .03 ~ : 고려대학교 의과대학 안산병원 조교수, 부교수, 교수
2012 .03 ~ : 고려대학교 안산병원 인공신장실장

논문

[SCI] (Renoprotective Effects of a Highly Selective A3 Adenosine Receptor Antagonist in a Mouse Model of Adriamycin-induced Nephropathy)

[SCI] (Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice)

[SCI] (DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury)

[SCI] (Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet)

[SCI] (Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice)

[SCI] (Obesity associated hypertension: new insights into mechanism. (review))

[SCI] (The role of visfatin in diabetic nephropathy. (review))

[SCI] (The role of adipose tissue in diabetic kidney disease: INTECH open publisher (www.intechopen.com))

[SCI] (Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments (review))

[SCI] (Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice.)

[SCI] (Inhibition of integrin-linlked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.)

[SCI] (Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients.)

[SCI] (CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice.)

[SCI] (Visfatin is upregulated in type-2 diabetic rats and targets renal cells.)

[SCI] (Aldosterone and diabetic kidney disease.)

[SCI] (A rare case of perinephric urinoma due to idiopathic retroperitoneal fibrosis.)

[SCI] (Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats)

[SCI] (Visfatin: A New Player in Mesangial Cell Physiology and Diabetic Nephropathy.)

[SCI] (Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue)

[국외논문] (Epithelial to mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria)

저서

저서 내용이 없습니다.

보도자료

보도자료 내용이 없습니다.

포스팅

포스팅 내용이 없습니다.

영상자료

영상자료 내용이 없습니다.

발표자료

발표자료 내용이 없습니다.